XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning balance at Dec. 31, 2023 $ 2,431,835 $ 7,175 $ 159,047 $ (366,262) $ 2,624,380 $ 7,495
Beginning balance (in shares) at Dec. 31, 2023   97,957        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 65,273       65,177 96
Other comprehensive (loss)/income            
Translation gain/(loss) (19,786)     (19,319)   (467)
Defined benefit plan adjustment, net of tax 43     43    
Derivative financial instruments, net of tax 169     169    
Derivative gain (loss), net of tax (19,574)     (19,107)   (467)
Dividends (50,348)       (50,348)  
Issuance of stock awards 204   204      
Issuance of stock awards (in shares)   460        
Shares repurchased (9,139)   (9,139)      
Shares repurchased (in shares)   (162)        
Share-based compensation 8,325   8,325      
Other 906   906      
Ending balance at Mar. 31, 2024 2,427,482 $ 7,175 159,343 (385,369) 2,639,209 7,124
Ending balance (in shares) at Mar. 31, 2024   98,255        
Beginning balance at Dec. 31, 2023 2,431,835 $ 7,175 159,047 (366,262) 2,624,380 7,495
Beginning balance (in shares) at Dec. 31, 2023   97,957        
Ending balance at Dec. 31, 2024 $ 2,286,213 [1] $ 7,175 183,250 (502,734) 2,583,923 14,599
Ending balance (in shares) at Dec. 31, 2024 98,260 98,260        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 54,489       54,429 60
Other comprehensive (loss)/income            
Translation gain/(loss) 175,839     175,864   (25)
Defined benefit plan adjustment, net of tax 544     544    
Derivative financial instruments, net of tax 1,757     1,757    
Derivative gain (loss), net of tax 178,140     178,165   (25)
Divestiture of noncontrolling interests (637)         (637)
Dividends (51,558)       (51,558)  
Dividends paid to noncontrolling interests (243)         (243)
Issuance of stock awards 273   273      
Issuance of stock awards (in shares)   588        
Shares repurchased (10,573)   (10,573)      
Shares repurchased (in shares)   (220)        
Share-based compensation 5,828   5,828      
Ending balance at Mar. 30, 2025 $ 2,461,932 $ 7,175 $ 178,778 $ (324,569) $ 2,586,794 $ 13,754
Ending balance (in shares) at Mar. 30, 2025 98,628 98,628        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the “United States” or “U.S.”).